NEW YORK (GenomeWeb News) – Life Technologies today announced that it has received marketing clearance in Japan for its 7500 Fast Dx Real-Time PCR instrument and 3500 Dx Series Genetic Analyzer.
The firm said that it filed the platforms were filed as diagnostic application instruments with the Tokyo Metropolitan Government in March. It plans to sell the systems in Japan for in vitro diagnostic use.
Life Tech said that clinical labs and institutions in Japan developing molecular diagnostics for oncology, genetic diseases, and infectious diseases would now be able to use the 7500 Fast Dx system to develop tests for clinical applications. The 3500 Dx Series, a capillary electrophoresis system for nucleic acid analysis, is intended for analyzing DNA or RNA for the detection of genetic changes that may lead to disease presence or susceptibility.
"These devices will enable physicians and laboratories to rapidly develop new clinical and diagnostic assays using a platform they are familiar with," Joydeep Goswami, head of Life Technologies Japan, said in a statement. "We will work closely with the developers of these assays to assist them in bringing their assays to patients quickly and safely."